Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of […]

Venezuela-Cuba business opportunities forum meets

(KPL/Prensa Latina) The Venezuela-Cuba Business Opportunities Forum will meet in Caracas to promote the presence of Venezuelan products and services at the upcoming Havana International Fair (FIHAV).

Venezuelan authorities from the Foreign Trade Ban…

Prabowo Subianto sworn in as eighth President of Indonesia

(KPL/VNA) Prabowo Subianto was sworn in as the eighth President of Indonesia, and Gibran Rakabuming Raka as Vice President at a ceremony held at the Nusantara Building in the Senayan legislative complex in Jakarta on October 20.

More than 30 heads o…